Literature DB >> 10625452

Phosphatidylinositol-4,5-bisphosphate mediates the interaction of syndecan-4 with protein kinase C.

A Horowitz1, M Murakami, Y Gao, M Simons.   

Abstract

Recent studies have demonstrated that the cytoplasmic tail of syndecan-4, a widely expressed transmembrane proteoglycan, can activate protein kinase Calpha in vitro, in combination with phosphatidylinositol-4,5-bisphosphate (PI-4,5-P(2)). Syndecan-4 is involved in growth factor binding as well as in adhesion to extracellular matrix proteins, while PI-4,5-P(2) synthesis is modulated by growth factor and adhesion-generated signaling. The cooperative activation of PKCalpha by the proteoglycan and the phosphatidylinositol may constitute, therefore, an essential part of the cell's response to these extracellular signals. To characterize the activation mechanism of PKCalpha, we addressed here the nature of the interplay between syndecan-4, PI-4,5-P(2), and PKCalpha by measuring their mutual binding affinities and the specificity of their interactions. We found that the cytoplasmic tail of syndecan-4 is unlikely to bind directly to PKCalpha, and that this interaction critically depends on PI-4,5-P(2). The PI-4,5-P(2) specificity of the activation of PKCalpha is conferred by the cytoplasmic tail of syndecan-4, which has higher binding affinity for this phosphatidylinositol over phosphatidylinositol-3,4-bisphosphate and the -3,4,5-trisphospate. The activation is specific to PKCalpha and does not encompass the novel protein kinase C delta isoenzyme.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10625452     DOI: 10.1021/bi991363i

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  28 in total

1.  Syndecan-4 cytoplasmic domain regulation of turkey satellite cell focal adhesions and apoptosis.

Authors:  Yan Song; Douglas C McFarland; Sandra G Velleman
Journal:  Mol Biol Rep       Date:  2012-06-02       Impact factor: 2.316

2.  Syndecan-4 proteoliposomes enhance fibroblast growth factor-2 (FGF-2)-induced proliferation, migration, and neovascularization of ischemic muscle.

Authors:  Eugene Jang; Hassan Albadawi; Michael T Watkins; Elazer R Edelman; Aaron B Baker
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

Review 3.  Mechanoregulation of gene expression in fibroblasts.

Authors:  James H-C Wang; Bhavani P Thampatty; Jeen-Shang Lin; Hee-Jeong Im
Journal:  Gene       Date:  2007-01-31       Impact factor: 3.688

4.  Structural and cell adhesion properties of zebrafish syndecan-4 are shared with higher vertebrates.

Authors:  James R Whiteford; Sunggeon Ko; Weontae Lee; John R Couchman
Journal:  J Biol Chem       Date:  2008-08-26       Impact factor: 5.157

5.  A syndecan-4 binding peptide derived from laminin 5 uses a novel PKCε pathway to induce cross-linked actin network (CLAN) formation in human trabecular meshwork (HTM) cells.

Authors:  Mark S Filla; Ross Clark; Donna M Peters
Journal:  Exp Cell Res       Date:  2014-08-13       Impact factor: 3.905

6.  Changes in glycosaminoglycan structure on differentiation of human embryonic stem cells towards mesoderm and endoderm lineages.

Authors:  Leyla Gasimli; Anne Marie Hickey; Bo Yang; Guoyun Li; Mitche dela Rosa; Alison V Nairn; Michael J Kulik; Jonathan S Dordick; Kelley W Moremen; Stephen Dalton; Robert J Linhardt
Journal:  Biochim Biophys Acta       Date:  2014-01-09

Review 7.  Syndecan-4: dispensable or indispensable?

Authors:  Sarah A Wilcox-Adelman; Fabienne Denhez; Tokuro Iwabuchi; Stefania Saoncella; Enzo Calautti; Paul F Goetinck
Journal:  Glycoconj J       Date:  2002 May-Jun       Impact factor: 2.916

Review 8.  Cytoplasmic interactions of syndecan-4 orchestrate adhesion receptor and growth factor receptor signalling.

Authors:  Mark D Bass; Martin J Humphries
Journal:  Biochem J       Date:  2002-11-15       Impact factor: 3.857

9.  A role for Syndecan-4 in neural induction involving ERK- and PKC-dependent pathways.

Authors:  Sei Kuriyama; Roberto Mayor
Journal:  Development       Date:  2009-01-14       Impact factor: 6.868

10.  Suppression of RhoG activity is mediated by a syndecan 4-synectin-RhoGDI1 complex and is reversed by PKCalpha in a Rac1 activation pathway.

Authors:  Arye Elfenbein; John M Rhodes; Julia Meller; Martin A Schwartz; Michiyuki Matsuda; Michael Simons
Journal:  J Cell Biol       Date:  2009-07-06       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.